Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas
PaperCitations, authors & open-access status
A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 143 citations, 2011 year and bronze oa status.
143
Citations
2011
Year
bronze
OA Status